Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Assets (2017 - 2025)

Neuronetics (STIM) has disclosed Assets for 9 consecutive years, with $145.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets rose 96.26% to $145.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $145.5 million, a 96.26% increase, with the full-year FY2024 number at $140.9 million, up 21.65% from a year prior.
  • Assets was $145.5 million for Q3 2025 at Neuronetics, up from $134.6 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $152.3 million in Q1 2021 to a low of $74.1 million in Q3 2024.
  • A 5-year average of $122.3 million and a median of $123.0 million in 2022 define the central range for Assets.
  • Peak YoY movement for Assets: decreased 22.01% in 2023, then skyrocketed 96.26% in 2025.
  • Neuronetics' Assets stood at $141.2 million in 2021, then dropped by 17.23% to $116.9 million in 2022, then fell by 0.9% to $115.8 million in 2023, then rose by 21.65% to $140.9 million in 2024, then grew by 3.24% to $145.5 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Assets are $145.5 million (Q3 2025), $134.6 million (Q2 2025), and $142.0 million (Q1 2025).